The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Thermo Fisher Scientific, Horizon Discovery, OriGene Technologies, QIAGEN, and GeneCopoeia Lead the Competition MicroRNA ...

The UK is poised to lead the next great leap in agriculture, with gene-editing technology offering a lifeline to a ...

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

A new report from McLean & Company, one of the world's leading HR research and advisory firms, highlights the critical ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications; Inno ...

A UCSF study reveals that maternal X chromosome expression may accelerate brain aging and cognitive decline. Female mice with ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $945.56, a high ...